药学学报, 2018, 53(12): 1943-1953
引用本文:
贾晓斌, 杨冰, 封亮, 石心红, 汪豪, 刘利根. 中药药剂学研究前沿:组分制剂技术基础与关键科学问题[J]. 药学学报, 2018, 53(12): 1943-1953.
JIA Xiao-bin, YANG Bing, FENG Liang, SHI Xin-hong, WANG Hao, LIU Li-gen. Research frontiers of Chinese medicine pharmaceutics: foundations and key issues of components preparation technology[J]. Acta Pharmaceutica Sinica, 2018, 53(12): 1943-1953.

中药药剂学研究前沿:组分制剂技术基础与关键科学问题
贾晓斌1, 杨冰2, 封亮1, 石心红1, 汪豪1, 刘利根1
1. 中国药科大学中药学院, 江苏 南京 211198;
2. 南京中医药大学, 江苏 南京 210023
摘要:
组分制剂在遵循中药整体性和系统性的基础上,将中药多成分的复杂问题简易化,为中药制剂的发展提供了一种有效的、可行的模式,已成为中药制剂研究的热点,也被认为是实现中药现代化的有效途径之一。本文在既往组分相关研究的基础上,结合本课题组的研究工作,重点针对组分性质及其表征技术、组分释药单元的构建及多元释药系统等方面阐述组分的研究前沿,探讨组分制剂技术基础与关键问题,为相关研究者带来一定的启发及思考。
关键词:    组分结构理论      中药组分性质      组分制剂技术      多元释药系统     
Research frontiers of Chinese medicine pharmaceutics: foundations and key issues of components preparation technology
JIA Xiao-bin1, YANG Bing2, FENG Liang1, SHI Xin-hong1, WANG Hao1, LIU Li-gen1
1. School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China;
2. Nanjing University of Chinese Medicine, Nanjing 210023, China
Abstract:
Based on the integrity and systematicness of Chinese medicine, the components preparation simplifies the complex problems of multi-components of Chinese medicine, provides an effective and feasible model for the development of Chinese medicine preparation. It has become a hot topic in the research of prep-aration, and is also considered as one of the effective ways to realize the modernization of Chinese medicine. Based on the previous research on multi-components and the work of our research group, the research frontiers of multi-components are elucidated, including the properties and characterization techniques of components, the construction of components release unit, and the multiple drug delivery system. The purpose of this paper is to explore the technical basis and key problem of components preparation, and then bring some inspiration and thought to the relevant researchers.
Key words:    structural composition of multi-components theory    Chinese medicine components property    Chinese medicine components preparation technology    multiunit drug delivery system   
收稿日期: 2018-08-06
DOI: 10.16438/j.0513-4870.2018-0717
基金项目: 国家自然科学基金资助项目(81573620);江苏省六大人才高峰创新团队资助项目(SWYY-CXTD-004);中国药科大学双一流建设创新团队(CPU2018GY11,CPU2018GF07).
通讯作者: 贾晓斌,Tel:86-25-86185239,E-mail:jiaxiaobin2015@163.com
Email: jiaxiaobin2015@163.com
相关功能
PDF(559KB) Free
打印本文
0
作者相关文章
贾晓斌  在本刊中的所有文章
杨冰  在本刊中的所有文章
封亮  在本刊中的所有文章
石心红  在本刊中的所有文章
汪豪  在本刊中的所有文章
刘利根  在本刊中的所有文章

参考文献:
[1] Feng L, Zhang MH, Gu JF, et al. Innovation and practice of component structure theory on material basis of traditional Chinese medicine prescriptions[J]. China J Chin Mater Med (中国中药杂志), 2013, 38:3603-3607.
[2] Jia XB, Chen Y, Li X, et al. New thoughts and methods of studying material base of traditional Chinese herbal formula[J]. China J Tradit Chin Med Pharm (中华中医药杂志), 2008, 23:420-425.
[3] Yang N, Feng L, Jia XB. Scalability and extensionality of innovative Chinese medicine preparation under guidance of component structure theory[J]. China J Chin Mater Med (中国中药杂志), 2016, 41:144-149.
[4] Ke ZC. Characterization of Biopharmaceutical Properties of Chishao Terpene Glucoside Components Based on Identification of Gepresentative Components (防治心肌缺血的赤芍萜苷组分代表性成分发现和生物药剂学性质表征)[D]. Nanjing:Nanjing University of Chinese Medicine, 2018.
[5] Charifson PS, Walters WP. Acidic and basic drugs in medicinal chemistry:a perspective[J]. J Med Chem, 2014, 57:9701-9717.
[6] Yun YE, Edginton AN. Correlation-based prediction of tissue-to-plasma partition coefficients using readily available input parameters[J]. Xenobiotica, 2013, 43:839-852.
[7] Hao TY, Wei YF, Qian SA, et al. Advances in strategies of improving solubility and permeability of taxanes[J]. Acta Pharm Sin (药学学报), 2018, 53:54-61.
[8] He FY, Deng KW, Liu WL, et al. Experimental studies on pharmacokinetics of three components in Buyanghuanwu injection on base of total quantum statistical moment[J]. China J Chin Mater Med (中国中药杂志), 2013, 38:253-262.
[9] Hao HP, Zheng CN, Wang GJ. Thoughts and experimental exploration on pharmacokinetic study of herbal medicines with multiple-components and targets[J]. Acta Pharm Sin (药学学报), 2009, 44:270-275.
[10] Yue PF, Zheng Q, Zhu GH, et al. "Total amount" release kinetics evaluation of traditional Chinese medicine sustained-release preparations based on material rough set theory[J]. Acta Pharm Sin (药学学报), 2010, 45:1354-1360.
[11] Zhan S, Guo W, Shao Q, et al. A pharmacokinetic and pharmacodynamic study of drug-drug interaction between ginsenoside Rg1, ginsenoside Rb1 and schizandrin after intravenous administration to rats[J]. J Ethnopharmacol, 2014, 152:333-339.
[12] Qin XL, Duan WH, Wang Y, et al. Effect of six bioactive lignans of Wuzhi tablet (Schisandra sphenanthera extract) on P-glycoprotein and its herb-drug interaction with digoxin[J]. Acta Pharm Sin (药学学报), 2018, 53:1337-1343.
[13] Zhang SN, Li XZ, Lu F, et al. New direction in Chinese materia medica toxicity study:discovery of potential toxicity in "non-toxic" drug[J]. World Sci Technol/Mod Tradit Chin Med Mater Med (世界科学技术-中医药现代化), 2015, 17:627-632.
[14] Wang YG, Ma ZC, Liang QD, et al. Thoughts and methods for toxicity study on Chinese materia medica[J]. Chin Tradit Herb Drugs (中草药), 2012, 43:1875-1879.
[15] Jia XB, Shi F, Huang Y, et al. In vivo and in vitro anti-lung cancer activity of Sancaofang components and their compatibility[J]. Chin Tradit Herb Drugs (中草药), 2010, 41:592-596.
[16] Liu D, Jia XB, Xiao W. Equilibrium solubility of Ginkgo flavonoid components in water and PBS of different pHs with mass fraction weight coefficient method[J]. China J Chin Mater Med (中国中药杂志), 2013, 38:1871-1875.
[17] Yan HM, Chen XY, Xia JH, et al. Evaluation on contribution rate of each component total salvianolic acids and characterization of apparent oil/water partition coefficient[J]. China J Chin Mater Med (中国中药杂志), 2015, 40:430-436.
[18] Liu D, Feng L, Song J, et al. Research thinking and strategy on overall biopharmaceutics classification system of Chinese materia medica composition[J]. Chin Tradit Herb Drugs (中草药), 2017, 48:4831-4835.
[19] Pérez-Sánchez A, Borrás-Linares I, Barrajón-Catalán E, et al. Evaluation of the intestinal permeability of rosemary (Rosmarinus officinalis L.) extract polyphenols and terpenoids in Caco-2 cell monolayers[J]. PLoS One, 2017, 12:e0172063.
[20] Liu D, Jia XB, Xiao W. Study on solubility of ginkgolide components with mass fraction weight coefficient method[J]. China J Chin Mater Med (中国中药杂志), 2013, 38:1865-1870.
[21] Amidon GL, Lennernas H, Shah VP, et al. A theoretical basis for a biopharmaceutic drug classification:the correlation of in vitro drug product dissolution and in vivo bioavailability[J]. Pharm Res, 1995, 12:413-420.
[22] Yu DH, Liu D, Zhang ZH, et al. Design technology of traditional Chinese medicine component and formulation[J]. China J Chin Mater Med (中国中药杂志), 2012, 37:2993-2996.
[23] Cong W, Shen L, Xu D, et al. Solid dispersion tablets of breviscapine with polyvinylpyrrolidone K30 for improved dissolution and bioavailability to commercial breviscapine tablets in beagle dogs[J]. Eur J Drug Metab Pharmacokinet, 2014, 39:203-210.
[24] Pan Y, Qian D, Liu P, et al. The influence of essential oils from Xiang-Fu-Si-Wu Decoction on its non-volatile components and its application for pharmacokinetics in normal rats[J]. J Chromatogr B, 2017, 1060:221-230.
[25] Zhang DK, Lin JZ, Liu JY, et al. Powder modification technology used for the preparation of the hydrophilic decoction pieces of Indigo Naturalis and the modification principle[J]. Acta Pharm Sin (药学学报), 2013, 48:1148-1155.
[26] Zhu ZT, Pan JH, Wu XH, et al. Screen absorption enhancer for intranasal administration preparations of paeoniflorin based on nasal perfusion method in rats[J]. China J Chin Mater Med (中国中药杂志), 2017, 42:493-497.
[27] Wei J, He HL, Zheng CL, et al. Chitosan-coated ophthalmic submicro emulsion for pilocarpine nitrate[J]. Acta Pharm Sin (药学学报), 2011, 46:990-996.
[28] Yu F, Li Y, Chen Q, et al. Monodisperse microparticles loaded with the self-assembled berberine-phospholipid complex-based phytosomes for improving oral bioavailability and enhancing hypoglycemic efficiency[J]. Eur J Pharm Biopharm, 2016, 103:136-148.
[29] Jiao J, Sun L, Guo Z, et al. Antibacterial and anticancer PDMS surface for mammalian cell growth using the Chinese herb extract paeonol (4-methoxy-2-hydroxyacetophenone)[J]. Sci Rep, 2016, 6:38973.
[30] Fan B, Jin MJ, Huang W, et al. The development of cell-penetrating peptides in drug delivery system[J]. Acta Pharm Sin (药学学报), 2016, 51:264-271.
[31] Li M, Hou SX, Mao SJ, et al. Preparation and dissolution characteristics of compound Danshen freeze-dried emulsion[J]. Chin Tradit Herb Drugs (中草药), 2017, 48:2632-2637.
[32] Tang HX, Zhang ZH, Zhao ZY, et al. Research progress of lactoferrin as drug carriers[J]. Acta Pharm Sin (药学学报), 2015, 50:675-681.
[33] Ji YB, Zhou XX, Guo RQ, et al. Honokiol nanosuspensions:preparation, in vitro and in vivo evaluation[J]. Acta Pharm Sin (药学学报), 2018, 53:133-140.
[34] Peng CC, Zheng Q, Hu PY, et al. Drug release of compound salvia multi-component released double-layer tablet[J]. Chin Tradit Pat Med (中成药), 2010, 32:39-43.
[35] Yang M, Feng Y, Xu DS, et al. Technical lines for advanced TCM drug release system[J]. World Sci Technol/Mod Tradit Chin Med Mater Med (世界科学技术-中医药现代化), 2006, 8:10-15.
[36] Feng Y, Xu DS, Hong YL, et al. Studies on m arket of drug delivery system product and drug delivery system of compound Chinese Medicine[J]. China J Chin Mater Med (中国中药杂志), 2006, 31:1669-1670, 1688.
[37] Sun E, Jia XB, Huang Y, et al. Thought and application of traditional Chinese medicine multiple drug delivery system based on material basis component[J]. China J Chin Mater Med (中国中药杂志), 2012, 37:2181-2185.
[38] Song HT, Zhang Q, Wang HJ, et al. Preparation of the traditional Chinese medicine compound recipe Shuxiong sustained-release capsules by multiparticulate time-controlled explosion technology[J]. Pharmazie, 2007, 62:372-377.
[39] Liao ZG, Liang XL, Ping QN, et al. Formula design and optimization of Guizhi fuling doublelayers sustained-release tablet[J]. Chin Tradit Herb Drugs (中草药), 2009, 40:553-557.
[40] Li Y, Hou S, Bi Y, et al. Novel two-step release system for the traditional Chinese medicine compound Danshen[J]. Yakugaku Zasshi, 2007, 127:1473-1484.
[41] Huang Y. The Construction of Multi-drug Delivery System of Tongmai Micro-Pellets (通脉微丸多元释药系统的构建)[D]. Zhenjiang:Jiangsu University, 2011.
[42] Song HT, Guo T, Kang LP, et al. Shuxiong sustained-release capsule prepared by multiparticulate site-controlled release technique[J]. Chin Tradit Herb Drugs (中草药), 2005, 36:993-998.
[43] Wei YF, Zhang N, Lin X, et al. Release characteristics in vitro and pharmacokinetics of Da Chuanxiong Fang multiunit drug delivery system in rats[J]. Acta Pharm Sin (药学学报), 2011, 46:1150-1155.
[44] Zhang JW, Chen LB, Gu JK, et al. Novel method for the evaluation of the synchronicity of the chemomic release/dissolution of multi-component traditional Chinese medicines[J]. Acta Pharm Sin (药学学报), 2008, 43:647-651.
[45] Yue PF, Wu B, Zheng Q et al. Innovation and discussion on evaluation pattern of synchronism/asynchronism release characterization of sustained and controlled release preparations for Chinese herbal formula[J]. Chin Tradit Herb Drugs (中草药), 2010, 41:1413-1417.
[46] Li XY, Hao HP, Wang GJ, et al. Integrated pharmacokinetic study of multiple effective components contained in total Panax Notoginsenosides[J]. Chin J Nat Med (中国天然药物), 2008, 6:377-381.
[47] Zhang W, Song HT, Zhang Q. Evaluation on in vitro release of gastric floating sustained-release preparation of Tript-erygium wilf-ordii by HPLC fingerprints[J]. Chin Tradit Herb Drugs (中草药), 2010, 41:376-380.
[48] Zhao ZG, Zhang XM, Zhang MM, et al. Identification and determination of multiple components in Qianliexin capsules by HPLC-ESI-TOF/MS and study on the quantitative fingerprint[J]. Chin J Pharm Anal (药物分析杂志), 2017, 37:1810-1816.
[49] Zhang JW, Chen LB, Gu JK, et al. Novel theory and methods for chemomic multi-component release/dissolution kinetics of traditional Chinese medicines[J]. Chin J Nat Med (中国天然药物), 2008, 6:48-52.
[50] Lai HQ, Hu Y, Li XD. The in vitro dissolution of total composition of the tablet of rhizomes of Ligusticum chuanxiong components and in vitro-in vivo correlation by the method of area under the absorbance-wavelength curve[J]. Acta Pharm Sin (药学学报), 2015, 50:788-792.